
8.01MUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US8169441024
CUSIP
81726A100
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
-0.31
Dividend Share
-
Dividend Yield
-
Earnings Share
-46.2
Wall Street Target Price
445.50
EPS Estimate Current Year
-34.49
EPS Estimate Next Year
-31.35
EPS Estimate Current Quarter
-0.295
EPS Estimate Next Quarter
-0.325
Most Recent Quarter
-
Revenue TTM
74,000
Gross Profit TTM
-7,686,000
EBITDA
-43,236,000
Profit Margin
0.00%
Return On Assets TTM
-71.16%
Return On Equity TTM
-466.46%
Revenue Per Share TTM
0.002
Qtly Revenue Growth YOY
-100.00%
Diluted Eps TTM
-46.2
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
105.22
Price Book MRQ
5.4519
Enterprise Value Revenue
328
Enterprise Value EBITDA
0
965.00
0.00%128.26
0.00%390.94
-2.36%151.52
-2.31%925.70
-1.93%32.39
-1.88%318.32
-1.17%516.11
-1.04%917.00
-0.91%199.30
-0.11%